$35MSeries A, 12 August 2025
Funds early clinical testing of JN-0413 ahead of a 2026 IND filing.
- Amount
- $35M
- Stage
- Series A
- Announced
- 12 August 2025
- Lead
- True Ventures
- Other investors
- Moore Strategic Ventures, SC8 Investments, Glentura, Yagan Family Foundation
- Use of funds
- Funds early clinical testing of JN-0413 ahead of a 2026 IND filing.
- Checked
- Announced by the company
- Sources
- Jocasta Neuroscience raises $35M Series A (date approx) biospace.com
Jocasta Neuroscience raises $35M Series A (date approx) pulse2.com